JTH/LinkedIn
Jun 23, 2026, 13:44
How Sickle Hemoglobin Fuels Thrombosis and Vascular Injury – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Jintao Wang et al, published in Journal of Thrombosis and Haemostasis, adding:
“Sickle hemoglobin promotes venous thrombosis through procoagulant activity and is targetable by hemoglobinase therapy
In sickle cell disease mice, sickle hemoglobin shortens clotting time and drives venous thrombosis, while hemoglobinase (plasmepsin I) therapy reduces free hemoglobin and thrombus size.”
Title: Sickle hemoglobin promotes venous thrombosis through procoagulant activity and is targetable by hemoglobinase therapy
Authors: Jintao Wang, Paul Silaghi, Daniel T. Eitzman

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics